Skip to content

A study for skin condition by intake a food to be examined by UV irradiation. -A placebo-controlled, randomized, double-blind, cross-over trial-

A study for skin condition by intake a food to be examined by UV irradiation. -A placebo-controlled, randomized, double-blind, cross-over trial- - A study for skin condition by intake a food to be examined by UV irradiation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039082
Enrollment
28
Registered
2020-01-09
Start date
2020-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 1 capsule of test food three times a day after breakfast, lunch, and dinner for 8 weeks and until the morning of the 7th day of MED irradiation after taking 8 weeks. Do not take two capsules at o

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Male and female from 30 to 45 years old with no skin disorders. (2) Subjects with BMI of 18.5 or more and less than 30. (3) Subjects whose skin photo type is Type I or II (4) Subjects who can judge UV erythema on the inner skin of the upper arm. (5) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: (1) Subjects who have been diagnosed with photosensitivity. (2) Subjects taking drugs that affect skin photosensitivity. (3) Subjects who are currently visiting a dermatologist or are being treated for other diseases. (4) Subjects with a history of sugar metabolism, lipid metabolism, liver function, renal function, heart, cardiovascular, respiratory and endocrine systems. (5) Subjects who regularly take medicines or health foods that are said to have moisturizing and whitening effects. (6) Subjects with symptoms of atopic dermatitis. (7) Subjects with significant abnormal skin condition at the test site, or subjects with sunburn. (8) Subjects with severe hay fever symptoms. (9) Subjects who continuously use or take anti-inflammatory drugs at least once a month. (10) Subjects who are using or taking drugs such as oral or liniment because of rough skin. (11) Subjects with food allergies to olive-containing foods. (12) Night shift worker or day and night shift workers. (13) Subjects with a digestive organ disease or surgical history that has an influence on digestive absorption. (14) Subjects who are judged to be inappropriate as subjects from the answers to the subject background questionnaire. (15) Subjects who are pregnant or breast-feeding, or have the will of pregnancy during the study period. (16) Subjects who has a medical history or current medical history of drug dependence or alcohol dependence. (17) Subjects who have participated in similar UV irradiation studies within the last two years. (18) Subjects who participate in other human studies within the last 4 weeks or who plan to participate in other human studied during the period of this study. (19) Subjects who are judged as unsuitable for the study by the investigator for the other reasons.

Design outcomes

Primary

MeasureTime frame
1. MED judgment by the responsible or assigned doctor. 2. Stratum corneum moisture content. 3. Skin viscoelasticity.

Secondary

MeasureTime frame
Conduct VAS on the skin every week during the intake period (9 times in total) for: Skin viscoelasticity, Skin clarity, Youthfulness (visual impression), Improvement of rough skin, Improvement of fine wrinkles, improvement of dull skin, Improvement of laugh line.

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales Department

eigyou27@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026